Jim Simons Medical Devices

Renaissance Technologies LLC

$70.6 Billion
Q2 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
BSX Boston Scientific Corp	$141B	$161 Million 0.23% of portfolio	1,496,541	Q2 2025 Added 129.69%
PODD Insulet Corp	$22.4B	$118 Million 0.17% of portfolio	374,256	Q2 2025 Added 135.1%
EW Edwards Lifesciences Corp	$46.5B	$81.4 Million 0.12% of portfolio	1,040,386	Q2 2025 Added 3.36%
DXCM Dexcom Inc	$29.5B	$60.9 Million 0.09% of portfolio	697,802	Q2 2025 Added 10.63%
UFPT Ufp Technologies Inc	$1.54B	$57 Million 0.08% of portfolio	233,259	Q2 2025 Reduced 10.17%
MDT Medtronic PLC	$126B	$37.7 Million 0.05% of portfolio	432,541	Q2 2025 New
INMD In Mode Ltd.	$1.24B	$33.6 Million 0.05% of portfolio	2,326,518	Q2 2025 Added 0.85%
IRMD Iradimed Corp	$900M	$29.4 Million 0.04% of portfolio	491,812	Q2 2025 Reduced 1.97%
IRTC I Rhythm Technologies, Inc.	$5.17B	$21.7 Million 0.03% of portfolio	141,200	Q2 2025 Added 538.91%
INSP Inspire Medical Systems, Inc.	$2.3B	$16.5 Million 0.02% of portfolio	126,800	Q2 2025 Reduced 33.51%
LIVN Liva Nova PLC	$2.92B	$8.54 Million 0.01% of portfolio	189,694	Q2 2025 Added 266.96%
ATEC Alphatec Holdings, Inc.	$1.58B	$8.26 Million 0.01% of portfolio	744,200	Q2 2025 Added 243.79%
SIBN Si Bone, Inc.	$519M	$7.9 Million 0.01% of portfolio	419,700	Q2 2025 Added 96.95%
BRKR Bruker Corp	$4.76B	$7.24 Million 0.01% of portfolio	175,810	Q2 2025 Reduced 38.03%
TNDM Tandem Diabetes Care Inc	$782M	$6.38 Million 0.01% of portfolio	342,327	Q2 2025 Added 19.64%
GMED Globus Medical Inc	$4.33B	$6.22 Million 0.01% of portfolio	105,418	Q2 2025 Reduced 40.41%
STE Steris PLC	$24.9B	$5.94 Million 0.01% of portfolio	24,708	Q2 2025 New
ANIK Anika Therapeutics, Inc.	$126M	$5.58 Million 0.01% of portfolio	527,217	Q2 2025 Reduced 0.26%
RXST Rx Sight, Inc.	$255M	$5.54 Million 0.01% of portfolio	426,400	Q2 2025 Reduced 5.58%
BVS Bioventus Inc.	$442M	$5.24 Million 0.01% of portfolio	790,818	Q2 2025 Added 42.88%
OFIX Orthofix Medical Inc.	$295M	$5.23 Million 0.01% of portfolio	469,201	Q2 2025 Added 410.06%
INGN Inogen Inc	$196M	$5.1 Million 0.01% of portfolio	726,106	Q2 2025 Reduced 0.64%
FONR Fonar Corp	$103M	$4.72 Million 0.01% of portfolio	315,516	Q2 2025 Added 3.65%
ELMD Electromed, Inc.	$209M	$4.45 Million 0.01% of portfolio	202,204	Q2 2025 Added 33.64%
ZIMV Zim Vie Inc.	$493M	$3.91 Million 0.01% of portfolio	418,500	Q2 2025 Added 16.25%
BWAY Brainsway Ltd.	$276M	$3.73 Million 0.01% of portfolio	283,860	Q2 2025 Reduced 4.83%
TCMD Tactile Systems Technology Inc	$275M	$3.71 Million 0.01% of portfolio	366,000	Q2 2025 Added 0.52%
CTKB Cytek Biosciences, Inc.	$528M	$3.61 Million 0.01% of portfolio	1,063,139	Q2 2025 Added 54.62%
ARAY Accuray Inc	$153M	$3.57 Million 0.01% of portfolio	2,604,384	Q2 2025 Reduced 4.37%
PEN Penumbra Inc	$9.71B	$3.36 Million 0.0% of portfolio	13,100	Q2 2025 New
SNN Smith & Nephew PLC	$16.2B	$2.95 Million 0.0% of portfolio	96,250	Q2 2025 New
VMD Viemed Healthcare, Inc.	$256M	$2.84 Million 0.0% of portfolio	410,300	Q2 2025 Added 6.74%
VREX Varex Imaging Corp	$458M	$2.65 Million 0.0% of portfolio	305,200	Q2 2025 Reduced 1.13%
DCTH Delcath Systems, Inc.	$94.8M	$2.42 Million 0.0% of portfolio	178,000	Q2 2025 Added 149.65%
AHCO Adapt Health Corp.	$1.2B	$2.13 Million 0.0% of portfolio	226,265	Q2 2025 Reduced 45.13%
SGHT Sight Sciences, Inc.	$168M	$1.88 Million 0.0% of portfolio	455,026	Q2 2025 Reduced 25.07%
MXCT Maxcyte, Inc.	$147M	$1.56 Million 0.0% of portfolio	717,800	Q2 2025 Added 95.11%
AXGN Axogen, Inc.	$692M	$1.54 Million 0.0% of portfolio	142,000	Q2 2025 Added 129.03%
NPCE Neuro Pace Inc	$244M	$1.44 Million 0.0% of portfolio	129,117	Q2 2025 Reduced 17.13%
ICAD Icad Inc	$98M	$1.33 Million 0.0% of portfolio	349,690	Q2 2025 Reduced 46.69%
SENS Senseonics Holdings, Inc.	$209M	$1.32 Million 0.0% of portfolio	2,754,927	Q2 2025 Reduced 41.71%
MASS 908 Devices Inc.	$190M	$1.24 Million 0.0% of portfolio	174,100	Q2 2025 Added 20.4%
SRTS Sensus Healthcare, Inc.	$52.2M	$1.19 Million 0.0% of portfolio	250,134	Q2 2025 Reduced 3.66%
AVNS Avanos Medical, Inc.	$551M	$1.18 Million 0.0% of portfolio	96,800	Q2 2025 Added 472.78%
MYO Myomo, Inc.	$5.74M	$1.17 Million 0.0% of portfolio	541,405	Q2 2025 Added 480.28%
CERS Cerus Corp	$213M	$1.08 Million 0.0% of portfolio	765,500	Q2 2025 Reduced 44.1%
BFLY Butterfly Network, Inc.	$287M	$1.01 Million 0.0% of portfolio	505,753	Q2 2025 Added 21.52%
QTRX Quanterix Corp	$184M	$686,000 0.0% of portfolio	103,200	Q2 2025 Reduced 49.14%
LUNG Pulmonx Corp	$59.3M	$650,000 0.0% of portfolio	251,310	Q2 2025 Added 52.03%
CLPT Clear Point Neuro, Inc.	$256M	$524,000 0.0% of portfolio	43,900	Q2 2025 Reduced 13.92%

Shares Options

Jim Simons

Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.

Track Jim Simons's portfolio

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account